Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$127,755,821
+$3,333,092 QoQ
Shares Held
2,994,745
+16.0% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#17
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Derivatives in SNY
reported options exposure · as of Jun 30, 2024CallValue
$1,455,600
CallShares
30,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $29,799,350,964 across 16 Drug Manufacturers - General names. SNY ranks #14 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,652,960 | $9,179,190,573 | |
| 2 | JNJ |
Johnson & Johnson
|
19,722,544 | $5,008,934,496 | |
| 3 | ABBV |
AbbVie Inc.
|
16,291,630 | $4,099,625,769 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,075,139 | $2,836,655,359 | |
| 5 | AZN |
Astrazeneca PLC
|
9,742,396 | $1,847,353,128 | |
| 6 | AMGN |
Amgen Inc
|
4,130,732 | $1,495,820,670 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
10,778,294 | $1,361,729,661 | |
| 8 | PFE |
Pfizer Inc
|
52,991,850 | $1,276,043,746 |
All Filings in SNY
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $127,755,821 | 2,994,745 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $124,422,729 | 2,582,456 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $95,834,640 | 1,977,603 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $117,024,281 | 2,479,328 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $127,667,966 | 2,642,682 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $153,911,260 | 2,775,176 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $137,847,512 | 2,858,128 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $210,558,926 | 3,653,634 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $160,499,986 | 3,307,914 | Shares | Defined | 2024-08-13 | |
| 2024-06-30 | $1,455,600 | 30,000 | Call | Defined | 2024-08-13 | |
| 2024-03-31 | $131,396,757 | 2,703,637 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $116,898,768 | 2,350,669 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $137,602,637 | 2,565,299 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $147,373,648 | 2,734,205 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $143,894,587 | 2,644,149 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $121,500,989 | 2,508,796 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $4,638,440 | 122,000 | Call | Defined | 2024-05-14 | |
| 2022-09-30 | $92,626,566 | 2,436,259 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $132,260,057 | 2,643,615 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $109,270,514 | 2,128,370 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $111,606,767 | 2,227,680 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $3,456,657 | 71,700 | Call | Defined | 2022-01-20 | |
| 2021-09-30 | $79,509,281 | 1,649,228 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $94,992,319 | 1,803,880 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $75,710,993 | 1,530,752 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $70,651,900 | 1,454,042 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $66,455,583 | 1,324,608 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $64,713,583 | 1,267,651 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $51,170,062 | 1,170,404 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||